Head and neck severity index is associated to a significant worsening of quality of life in atopic dermatitis patients-Reference-Cited by-同舟云学术

Head and neck severity index is associated to a significant worsening of quality of life in atopic dermatitis patients

Published:2021-05-31 Issue:11 Volume:30 Page:1717-1718
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Ribero Simone¹^ORCID,Puglisi Bruna¹,Giura Maria Teresa¹,Viola Riccardo¹,Siliquini Niccolo¹,Quaglino Pietro¹,Ortoncelli Michela¹

Affiliation:

1. Dermatology Clinic Medical Sciences Department University of Turin Turin Italy

Funder

LEO Pharma Research Foundation

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14368

Reference5 articles.

1. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches

3. Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA);Calzavara Pinton P;G Ital Dermatol Venereol,2018

4. Impact of Atopic Dermatitis Lesion Location on Quality of Life in Adult Patients in a Real-world Study

5. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real‐life Italian tertiary centre experience

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease burden, clinical management and unmet treatment need of patients with moderate to severe atopic dermatitis; consensus statements, insights and practices from CERTADE (Central/Eastern EU, Russia, Turkiye AD Experts) Delphi panel;Frontiers in Medicine;2024-06-19

2. Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch;Dermatology and Therapy;2024-05-22

3. Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis;Dermatology and Therapy;2024-05

4. Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab;Dermatitis®;2024-04-26

5. Head and neck atopic dermatitis: still a challenging manifestation in the biologic era;Expert Opinion on Biological Therapy;2023-06-14